{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T17:06:24Z","timestamp":1779296784611,"version":"3.51.4"},"reference-count":39,"publisher":"Oxford University Press (OUP)","issue":"16","license":[{"start":{"date-parts":[[2018,3,8]],"date-time":"2018-03-08T00:00:00Z","timestamp":1520467200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"SNSF Starting"},{"name":"Significant Pattern Mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,8,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Motivation<\/jats:title>\n                  <jats:p>Large-scale screenings of cancer cell lines with detailed molecular profiles against libraries of pharmacological compounds are currently being performed in order to gain a better understanding of the genetic component of drug response and to enhance our ability to recommend therapies given a patient's molecular profile. These comprehensive screens differ from the clinical setting in which (i) medical records only contain the response of a patient to very few drugs, (ii) drugs are recommended by doctors based on their expert judgment and (iii) selecting the most promising therapy is often more important than accurately predicting the sensitivity to all potential drugs. Current regression models for drug sensitivity prediction fail to account for these three properties.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>We present a machine learning approach, named Kernelized Rank Learning (KRL), that ranks drugs based on their predicted effect per cell line (patient), circumventing the difficult problem of precisely predicting the sensitivity to the given drug. Our approach outperforms several state-of-the-art predictors in drug recommendation, particularly if the training dataset is sparse, and generalizes to patient data. Our work phrases personalized drug recommendation as a new type of machine learning problem with translational potential to the clinic.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Availability and implementation<\/jats:title>\n                  <jats:p>The Python implementation of KRL and scripts for running our experiments are available at https:\/\/github.com\/BorgwardtLab\/Kernelized-Rank-Learning.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Supplementary information<\/jats:title>\n                  <jats:p>Supplementary data are available at Bioinformatics online.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/bioinformatics\/bty132","type":"journal-article","created":{"date-parts":[[2018,3,7]],"date-time":"2018-03-07T20:35:46Z","timestamp":1520454946000},"page":"2808-2816","source":"Crossref","is-referenced-by-count":54,"title":["Kernelized rank learning for personalized drug recommendation"],"prefix":"10.1093","volume":"34","author":[{"given":"Xiao","family":"He","sequence":"first","affiliation":[{"name":"Machine Learning and Computational Biology Lab, Department of Biosystems Science and Engineering, ETH Zurich, Basel, Switzerland"},{"name":"Swiss Institute of Bioinformatics, Basel, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5811-8875","authenticated-orcid":false,"given":"Lukas","family":"Folkman","sequence":"additional","affiliation":[{"name":"Machine Learning and Computational Biology Lab, Department of Biosystems Science and Engineering, ETH Zurich, Basel, Switzerland"},{"name":"Swiss Institute of Bioinformatics, Basel, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karsten","family":"Borgwardt","sequence":"additional","affiliation":[{"name":"Machine Learning and Computational Biology Lab, Department of Biosystems Science and Engineering, ETH Zurich, Basel, Switzerland"},{"name":"Swiss Institute of Bioinformatics, Basel, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2018,3,8]]},"reference":[{"key":"2023012712590062300_bty132-B1","doi-asserted-by":"crossref","first-page":"i413","DOI":"10.1093\/bioinformatics\/btw449","article-title":"TANDEM: a two-stage approach to maximize interpretability of drug response models based on multiple molecular data types","volume":"32","author":"Aben","year":"2016","journal-title":"Bioinformatics"},{"key":"2023012712590062300_bty132-B2","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1021\/ci500152b","article-title":"Integrative and personalized QSAR analysis in cancer by kernelized bayesian matrix factorization","volume":"54","author":"Ammad-ud-din","year":"2014","journal-title":"J. Chem. Inform. Model"},{"key":"2023012712590062300_bty132-B3","doi-asserted-by":"crossref","first-page":"i455","DOI":"10.1093\/bioinformatics\/btw433","article-title":"Drug response prediction by inferring pathway-response associations with kernelized bayesian matrix factorization","volume":"32","author":"Ammad-ud-din","year":"2016","journal-title":"Bioinformatics"},{"key":"2023012712590062300_bty132-B4","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/nature11003","article-title":"The cancer cell line encyclopedia enables predictive modelling of anticancer drug sensitivity","volume":"483","author":"Barretina","year":"2012","journal-title":"Nature"},{"key":"2023012712590062300_bty132-B5","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1023\/A:1010933404324","article-title":"Random forests","volume":"45","author":"Breiman","year":"2001","journal-title":"Mach. Learn"},{"key":"2023012712590062300_bty132-B6","author":"Broad Institute TCGA Genome Data Analysis Center","year":"2016"},{"key":"2023012712590062300_bty132-B7","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/S0140-6736(03)14023-8","article-title":"Gene expression profiling for the prediction of therapeutic response to docetaxel in patients with breast cancer","volume":"362","author":"Chang","year":"2003","journal-title":"Lancet"},{"key":"2023012712590062300_bty132-B8","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1056\/NEJMoa1103782","article-title":"Improved survival with vemurafenib in melanoma with BRAF V600E mutation","volume":"364","author":"Chapman","year":"2011","journal-title":"N. Engl. J. Med"},{"key":"2023012712590062300_bty132-B9","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/BF00994018","article-title":"Support-vector networks","volume":"20","author":"Cortes","year":"1995","journal-title":"Mach. Learn"},{"key":"2023012712590062300_bty132-B10","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1038\/nbt.2877","article-title":"A community effort to assess and improve drug sensitivity prediction algorithms","volume":"32","author":"Costello","year":"2014","journal-title":"Nat. Biotechnol"},{"key":"2023012712590062300_bty132-B11","doi-asserted-by":"crossref","first-page":"723.","DOI":"10.1038\/bjc.2016.41","article-title":"Phase 2 multicentre trial investigating intermittent and continuous dosing schedules of the poly(ADP-ribose) polymerase inhibitor rucaparib in germline BRCA mutation carriers with advanced ovarian and breast cancer","volume":"114","author":"Drew","year":"2016","journal-title":"Br. J. Cancer"},{"key":"2023012712590062300_bty132-B12","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/nature11005","article-title":"Systematic identification of genomic markers of drug sensitivity in cancer cells","volume":"483","author":"Garnett","year":"2012","journal-title":"Nature"},{"key":"2023012712590062300_bty132-B13","doi-asserted-by":"crossref","first-page":"R47.","DOI":"10.1186\/gb-2014-15-3-r47","article-title":"Clinical drug response can be predicted using baseline gene expression levels and in vitro drug sensitivity in cell lines","volume":"15","author":"Geeleher","year":"2014","journal-title":"Genome Biol"},{"key":"2023012712590062300_bty132-B14","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1101\/gr.221077.117","article-title":"Discovering novel pharmacogenomic biomarkers by imputing drug response in cancer patients from large genomics studies","volume":"27","author":"Geeleher","year":"2017","journal-title":"Genome Res"},{"key":"2023012712590062300_bty132-B15","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/ng.3756","article-title":"Precision oncology for acute myeloid leukemia using a knowledge bank approach","volume":"49","author":"Gerstung","year":"2017","journal-title":"Nat. Genet"},{"key":"2023012712590062300_bty132-B16","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1200\/JCO.2007.14.0590","article-title":"Efficacy and safety of lapatinib as first-line therapy for ErbB2-amplified locally advanced or metastatic breast cancer","volume":"26","author":"Gomez","year":"2008","journal-title":"J. Clin. Oncol"},{"key":"2023012712590062300_bty132-B17","doi-asserted-by":"crossref","first-page":"i556","DOI":"10.1093\/bioinformatics\/btu464","article-title":"Drug susceptibility prediction against a panel of drugs using kernelized bayesian multitask learning","volume":"30","author":"G\u00f6nen","year":"2014","journal-title":"Bioinformatics"},{"key":"2023012712590062300_bty132-B18","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.cell.2016.06.017","article-title":"A landscape of pharmacogenomic interactions in cancer","volume":"166","author":"Iorio","year":"2016","journal-title":"Cell"},{"key":"2023012712590062300_bty132-B19","first-page":"63","author":"Jang","year":"2014"},{"key":"2023012712590062300_bty132-B20","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1145\/582415.582418","article-title":"Cumulated gain-based evaluation of IR techniques","volume":"20","author":"J\u00e4rvelin","year":"2002","journal-title":"ACM Trans. Inform. Syst"},{"key":"2023012712590062300_bty132-B21","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1093\/biostatistics\/kxj037","article-title":"Adjusting batch effects in microarray expression data using empirical Bayes methods","volume":"8","author":"Johnson","year":"2007","journal-title":"Biostatistics"},{"key":"2023012712590062300_bty132-B22","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.tips.2015.08.009","article-title":"Targeted therapies for triple-negative breast cancer: combating a stubborn disease","volume":"36","author":"Kalimutho","year":"2015","journal-title":"Trends Pharmacol. Sci"},{"key":"2023012712590062300_bty132-B23","doi-asserted-by":"crossref","first-page":"36812.","DOI":"10.1038\/srep36812","article-title":"Logic models to predict continuous outputs based on binary inputs with an application to personalized cancer therapy","volume":"6","author":"Knijnenburg","year":"2016","journal-title":"Sci. Rep"},{"key":"2023012712590062300_bty132-B24","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/nav.3800020109","article-title":"The hungarian method for the assignment problem","volume":"2","author":"Kuhn","year":"1955","journal-title":"Nav. Res. Logist"},{"key":"2023012712590062300_bty132-B25"},{"key":"2023012712590062300_bty132-B26","doi-asserted-by":"crossref","first-page":"319.","DOI":"10.1038\/s41467-017-00388-9","article-title":"BRCA locus-specific loss of heterozygosity in germline BRCA1 and BRCA2 carriers","volume":"8","author":"Maxwell","year":"2017","journal-title":"Nat. Commun"},{"key":"2023012712590062300_bty132-B27","doi-asserted-by":"crossref","first-page":"e61318.","DOI":"10.1371\/journal.pone.0061318","article-title":"Machine learning prediction of cancer cell sensitivity to drugs based on genomic and chemical properties","volume":"8","author":"Menden","year":"2013","journal-title":"PLoS One"},{"key":"2023012712590062300_bty132-B28","doi-asserted-by":"crossref","first-page":"3177","DOI":"10.1182\/blood-2006-09-044974","article-title":"Gene expression profiling and correlation with outcome in clinical trials of the proteasome inhibitor bortezomib","volume":"109","author":"Mulligan","year":"2007","journal-title":"Blood"},{"key":"2023012712590062300_bty132-B29","volume-title":"Machine Learning: A Probabilistic Perspective","author":"Murphy","year":"2012"},{"key":"2023012712590062300_bty132-B30","first-page":"2825","article-title":"Scikit-learn: machine learning in Python","volume":"12","author":"Pedregosa","year":"2011","journal-title":"J. Mach. Learn. Res"},{"key":"2023012712590062300_bty132-B31","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1038\/nbt.2931","article-title":"Normalization of RNA-seq data using factor analysis of control genes or samples","volume":"32","author":"Risso","year":"2014","journal-title":"Nat. Biotechnol"},{"key":"2023012712590062300_bty132-B32","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1158\/2159-8290.CD-15-0235","article-title":"Harnessing connectivity in a large-scale small-molecule sensitivity dataset","volume":"5","author":"Seashore-Ludlow","year":"2015","journal-title":"Cancer Discov"},{"key":"2023012712590062300_bty132-B33","first-page":"311","article-title":"Bundle methods for regularized risk minimization","volume":"11","author":"Teo","year":"2010","journal-title":"J. Mach. Learn. Res"},{"key":"2023012712590062300_bty132-B34","doi-asserted-by":"crossref","first-page":"61.","DOI":"10.1038\/nature11412","article-title":"Comprehensive molecular portraits of human breast tumours","volume":"490","author":"The Cancer Genome Atlas Network","year":"2012","journal-title":"Nature"},{"key":"2023012712590062300_bty132-B35","first-page":"1453","article-title":"Large margin methods for structured and interdependent output variables","volume":"6(Sep)","author":"Tsochantaridis","year":"2005","journal-title":"J. Mach. Learn. Res"},{"key":"2023012712590062300_bty132-B36","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0140-6736(10)60892-6","article-title":"Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial","volume":"376","author":"Tutt","year":"2010","journal-title":"Lancet"},{"key":"2023012712590062300_bty132-B37","first-page":"1593","volume-title":"Advances in Neural Information Processing Systems 20","author":"Weimer","year":"2007"},{"key":"2023012712590062300_bty132-B38","doi-asserted-by":"crossref","first-page":"e1004498.","DOI":"10.1371\/journal.pcbi.1004498","article-title":"Predicting anticancer drug responses using a dual-layer integrated cell line-drug network model","volume":"11","author":"Zhang","year":"2015","journal-title":"PLoS Comput. Biol"},{"key":"2023012712590062300_bty132-B39","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1467-9868.2005.00503.x","article-title":"Regularization and variable selection via the elastic net","volume":"67","author":"Zou","year":"2005","journal-title":"J. R. Stat. Soc. B (Stat. Methodol.)"}],"container-title":["Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/bioinformatics\/article-pdf\/34\/16\/2808\/48917768\/bioinformatics_34_16_2808.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bioinformatics\/article-pdf\/34\/16\/2808\/48917768\/bioinformatics_34_16_2808.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,27]],"date-time":"2023-01-27T13:48:03Z","timestamp":1674827283000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bioinformatics\/article\/34\/16\/2808\/4924716"}},"subtitle":[],"editor":[{"given":"Jonathan","family":"Wren","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2018,3,8]]},"references-count":39,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2018,8,15]]}},"URL":"https:\/\/doi.org\/10.1093\/bioinformatics\/bty132","relation":{},"ISSN":["1367-4803","1367-4811"],"issn-type":[{"value":"1367-4803","type":"print"},{"value":"1367-4811","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,8,15]]},"published":{"date-parts":[[2018,3,8]]}}}